Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Tombolini

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
La Radiologia Medica|June 1, 1995
[Hodgkin's disease in stages I and IIA. Analysis of results in a group of patients with a follow-up of at least 10 years treated at the onset of the disease with radiotherapy alone]R Maurizi Enrici, M Falchetto Osti, A P Anselmo, et al.
Anticancer Research|June 9, 2001
Prognostic features and treatment outcome in patients with nasopharyngeal carcinoma: an experience of 20 yearsV Tombolini, V De Sanctis, V Donato, et al.
International Journal of Oral and Maxillofacial Surgery|November 26, 2018
Crestal bone loss around dental implants placed in head and neck cancer patients treated with different radiotherapy techniques: a prospective cohort studyP Papi, E Brauner, S Di Carlo, et al.
Oncology Reports|September 30, 2010
The impact of conventional or hypofractionated radiotherapy on voice quality and oncological outcome in patients with early glottic cancerL Di Nicola, G L Gravina, F Marampon, et al.
Cancer Treatment Reviews|October 14, 2017
Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutated patients: An evidence-based approach on what women should knowF De Felice, C Marchetti, S M Boccia, et al.
Critical Reviews in Oncology/Hematology|April 14, 2018
Dose-dense weekly chemotherapy in advanced ovarian cancer: An updated meta-analysis of randomized controlled trialsC Marchetti, F De Felice, A Di Pinto, et al.
European Review for Medical and Pharmacological Sciences|October 14, 2016
Unenhanced whole-body MRI versus PET-CT for the detection of prostate cancer metastases after primary treatmentF Barchetti, A Stagnitti, V Megna, et al.
Prostate Cancer and Prostatic Diseases|June 24, 2009
Subjective and objective measures of late genitourinary morbidity following hypofractionated radiotherapy in men with prostate cancerV Tombolini, M Di Staso, P Bonfili, et al.
Critical Reviews in Oncology/Hematology|November 19, 2018
Hormone replacement therapy after prophylactic risk-reducing salpingo-oophorectomy and breast cancer risk in BRCA1 and BRCA2 mutation carriers: A meta-analysisC Marchetti, F De Felice, S Boccia, et al.
Cancer Treatment Reviews|November 13, 2015
Tyrosine-kinases inhibitors in recurrent platinum-resistant ovarian cancer patientsC Marchetti, I Palaia, F De Felice, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
La Radiologia Medica|June 1, 1995
[Hodgkin's disease in stages I and IIA. Analysis of results in a group of patients with a follow-up of at least 10 years treated at the onset of the disease with radiotherapy alone]R Maurizi Enrici, M Falchetto Osti, A P Anselmo, et al.
Anticancer Research|June 9, 2001
Prognostic features and treatment outcome in patients with nasopharyngeal carcinoma: an experience of 20 yearsV Tombolini, V De Sanctis, V Donato, et al.
International Journal of Oral and Maxillofacial Surgery|November 26, 2018
Crestal bone loss around dental implants placed in head and neck cancer patients treated with different radiotherapy techniques: a prospective cohort studyP Papi, E Brauner, S Di Carlo, et al.
Oncology Reports|September 30, 2010
The impact of conventional or hypofractionated radiotherapy on voice quality and oncological outcome in patients with early glottic cancerL Di Nicola, G L Gravina, F Marampon, et al.
Cancer Treatment Reviews|October 14, 2017
Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutated patients: An evidence-based approach on what women should knowF De Felice, C Marchetti, S M Boccia, et al.
Critical Reviews in Oncology/Hematology|April 14, 2018
Dose-dense weekly chemotherapy in advanced ovarian cancer: An updated meta-analysis of randomized controlled trialsC Marchetti, F De Felice, A Di Pinto, et al.
European Review for Medical and Pharmacological Sciences|October 14, 2016
Unenhanced whole-body MRI versus PET-CT for the detection of prostate cancer metastases after primary treatmentF Barchetti, A Stagnitti, V Megna, et al.
Prostate Cancer and Prostatic Diseases|June 24, 2009
Subjective and objective measures of late genitourinary morbidity following hypofractionated radiotherapy in men with prostate cancerV Tombolini, M Di Staso, P Bonfili, et al.
Critical Reviews in Oncology/Hematology|November 19, 2018
Hormone replacement therapy after prophylactic risk-reducing salpingo-oophorectomy and breast cancer risk in BRCA1 and BRCA2 mutation carriers: A meta-analysisC Marchetti, F De Felice, S Boccia, et al.
Cancer Treatment Reviews|November 13, 2015
Tyrosine-kinases inhibitors in recurrent platinum-resistant ovarian cancer patientsC Marchetti, I Palaia, F De Felice, et al.
Pageof 7